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 Resumo 
 Introdução: A pancreatite paraduodenal constitui uma 
causa rara de dor abdominal crónica, caracterizada por 
processo inflamatório com consequente cicatrização no 
sulco entre a cabeça do pâncreas e a parede duodenal. 
Para além de dor abdominal, sintomas como vómitos e 
perda de peso são frequentes. Actualmente, com o desen-
volvimento dos métodos diagnósticos imagiológicos e 
endoscópicos, pode ser identificada sem necessidade de 
confirmação histológica, embora a diferenciação com o 
adenocarcinoma pancreático possa ser desafiante. Diver-
sas opções terapêuticas encontram-se disponíveis incluin-
do tratamento farmacológico, endoscópico ou cirúrgico. 
Métodos: Os autores descrevem três casos de pancreatite 
paraduodenal com diferentes atitudes terapêuticas. Re-
sultados e Conclusão: Estes demonstram que esta patolo-
gia deve ser considerada no diagnóstico diferencial de 
massas pancreáticas com infiltração duodenal e que a sua 
abordagem deve ser individualizada e judiciosa. 
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 Abstract 
 Background: Paraduodenal pancreatitis is a rare cause of 
chronic abdominal pain characterized by an inflammatory 
process and scarring in the groove area between the pancre-
atic head and the duodenal wall. Besides abdominal pain, 
symptoms such as vomiting and weight loss are common. 
Currently, advances in radiological and endoscopic diagnos-
tic methods allow it to be identified without histological 
confirmation, although the differentiation from pancreatic 
adenocarcinoma could be challenging in some cases. Many 
therapeutic options are available nowadays including phar-
macological, endoscopic, or surgical treatment.  Methods: 
We report 3 cases of paraduodenal pancreatitis that had dif-
ferent therapeutic approaches.  Results and Conclusion: 
They show that this pathology should be taken into account 
in the differential diagnosis of pancreatic masses with duo-
denal infiltration, and that its management should be indi-
vidualized and judicious. 
 © 2016 Sociedade Portuguesa de Gastrenterologia
Published by S. Karger AG, Basel 
 Received: March 31, 2016 
 Accepted after revision: July 3, 2016 
 Published online: November 22, 2016 
 Dr. Diana Carvalho 
 Gastroenterology and Hepatology Department, Hospital Santo António dos Capuchos
Centro Hospitalar de Lisboa Central 
 PT–1169–050 Lisbon (Portugal) 
 E-Mail dianafbcarvalho   @   gmail.com 
 © 2016 Sociedade Portuguesa de Gastrenterologia
Published by S. Karger AG, Basel
 
 www.karger.com/pjg Th is article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-








 Paraduodenal pancreatitis (PP) is a pathological con-
dition resulting from fibrotic inflammation that involves 
the duodenal wall closely to the minor papilla, the adja-
cent pancreatic parenchyma, and the area between them 
 [1] . Its pathophysiology remains unclear, although it is 
believed that alcohol consumption and the presence of 
ectopic pancreatic tissue in the duodenal wall may play a 
major role in its development  [2] . Through the last years, 
its treatment has been a topic of discussion in the litera-
ture, with the proposal of a wide range of conservative 
and surgical approaches  [3] . Nowadays, the consensus is 
to initially prefer medical or endoscopic treatment, sur-
gery being reserved to patients with uncertain diagnosis 
or symptoms that do not improve with other measures 
 [4] . 
 We present 3 cases of PP that were managed with 3 
different therapeutics procedures: supportive treatment, 
use of octreotide, and surgery with pancreaticoduodenec-
tomy. 
 Case 1 
 A 55-year-old male patient, with daily consumption of 130 g of 
alcohol and tobacco, was admitted to the Gastroenterology De-
partment for severe epigastric abdominal pain accompanied by 
anorexia, nausea, vomiting, and weight loss (3 kg). An upper gas-
trointestinal endoscopy was performed, revealing a bulb deformed 
by a vegetating lesion, not allowing visualization of the second du-
odenal portion (D2); histology was negative for malignancy. 
 During hospitalization, he improved with analgesia, intrave-
nous fluids, and bowel rest. Laboratory evaluation showed carbo-
hydrate antigen (CA) 19.9 of 61 ng/mL, with no other changes. 
Magnetic resonance imaging (MRI) showed a large abdominal le-
sion involving the bulb and D2, which was predominantly hyper-
intense on T2 and hypointense on T1, without significant contrast 
enhancement. In the pancreatic head, a cystic lesion was observed 
( Fig. 1 ). 
 Endoscopic ultrasound (EUS) revealed thickening of D2 (9 
mm) with microcysts in the wall, chronic pancreatitis and a cyst 
(21 mm) in the pancreatic head. Endoscopically, no irregularities 
of the duodenal mucosa were observed and passage to D2 was pos-
sible ( Fig. 2 ). Fine-needle aspiration (FNA) of the pancreatic cyst 
revealed an amylase of 108,643 U/L and carcinoembryonic antigen 
(CEA) 44.5 ng/mL on cytochemical examination.
 Reassessment imaging by computed tomography exhibited a 
significant regression of previous duodenal and pancreatic lesions. 
A presumptive diagnosis of PP was made. After multidisciplinary 
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 Fig. 1. MRI revealing an extensive oval lesion involving the duodenum bulb as well as D2 ( a ) and a pancreatic cyst ( b ). 
 Fig. 2. EUS showing thickening of the D2 
wall ( a ) and chronic pancreatitis ( b ). FNA 
of the pancreatic cyst ( c ). 
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team discussion, close monitoring was proposed with radiological 
examination, abstinence of alcohol, and smoking cessation. Dur-
ing the 13 months of follow-up, the patient remains asymptom-
atic, with no laboratory or radiological abnormalities.
 A close follow-up was decided in this case because of the favor-
able clinical response and the patient’s adherence to alcohol and 
tobacco abstinence. It is important to state that all current thera-
peutic alternatives (medical, endoscopic, or surgical) carry some 
degree of risk, which was deemed unwarranted in this case.
 Case 2 
 A 58-year-old female patient was referred to the Gastroenterol-
ogy Department for recurrent epigastric pain not related to food 
ingestion, with irradiation to the right abdominal flank, followed 
by nauseas. The patient had no history of addictive behavior. Blood 
tests revealed cholestatic changes (alkaline phosphatase 222 U/L 
and gamma-glutamyltransferase 82 U/L) and normal IgG4 levels. 
She was treated with ursodeoxycholic acid (1,000 mg/day) and 
pancreatin without clinical improvement. 
 A MRI was performed, showing parietal concentric thickening 
of D2 with apparent origin in the submucosal layer. Endoscopi-
cally, the duodenal mucosa was edematous, with decreased lumi-
nal caliber at this level; biopsies did not reveal any pathological 
changes. An EUS confirmed a slight hypoechoic thickening of the 
D2 wall (5 mm), especially for the submucosa, without cystic areas 
or other abnormalities in the echo structure. The pancreatic paren-
chyma was regular, but with marked atrophy of the body/tail seg-
ments ( Fig.  3 ). PP was diagnosed, and she started therapy with 
octreotide (20 mg with interval of 4 weeks). She had marked
pain reduction, with a sustained clinical response after 1 year of fol-
low-up. 
 The treatment’s choice was due to the persistence of pain de-
spite conservative measures (i.e. alcohol abstinence) and the ab-
sence of complications that could justify an endoscopic approach. 
In order to avoid a more invasive approach, the somatostatin ana-
log octreotide was considered the best option for symptomatic re-
lief.
 Case 3 
 A 56-year-old male patient with chronic consumption of alco-
hol (50 g/day) and tobacco (36 pack-year) was referred to the Gas-
troenterology Department for intense epigastric postprandial pain 
with 4 months of evolution. He also mentioned nauseas, vomiting, 
and weight loss (15 kg). Laboratory tests only showed hyperamy-
lasemia (312 U/L). He was treated with omeprazole 40 mg twice 
daily, domperidone 10 mg/day, and pregabalin 150 mg/day, with-
out symptomatic relief. 
 For clarification, an abdominal computed tomography was 
done, revealing D2 thickening (12 mm) with wall heterogeneity. 
EUS evidenced a heterogeneous circumferentially thickened duo-
denal wall (8.7 mm), mainly the third layer (submucosa), without 
focal lesions and a hypoechoic but homogeneous parenchyma in 
the pancreatic head ( Fig. 4 ).
 Over the next 2 months, the symptoms worsened, with con-
tinuous epigastric pain, uncontrollable vomiting, and weight loss 
(>20 kg). For this reason, the patient was admitted to the Gastro-
enterology Department and treated with fluid therapy and analge-
sia. He showed tolerance to mild oral diet but suffered moderate 
abdominal pain. Magnetic resonance cholangiopancreatography 
showed D2 thickening with heterogeneous contrast enhancement, 
areas of hyperintense signal, remaining cyst or necrosis, and mild 
heterogeneity of the pancreatic head contour ( Fig. 5 ).
 Our diagnostic hypotheses were PP versus duodenal malignan-
cy and, in a multidisciplinary meeting, it was decided to perform a 
pancreaticoduodenectomy (Transverse-Longmire). The surgery 
was performed without complications, and histological examina-
tion of the surgical specimen revealed cysts in the muscular layer 
coated with mucinous epithelium in the region of the minor pa-
pilla. Ectopic pancreatic tissue, Brunner’s gland hyperplasia, ab-
scesses, proliferation of smooth muscle cells, and fibrosis were also 
identified. These aspects confirmed the diagnosis of PP ( Fig. 6 ).
 Fifteen months after surgery, the patient remains asymptom-
atic with progressive increase of weight. In this patient, the defini-
tive diagnosis remained uncertain after the diagnostic work-up, 
making the surgical approach the best option for both treatment 
and etiologic confirmation.








 PP is a rare cause of chronic abdominal pain that has 
been described for the first time by Becker in 1973 as a 
segmental pancreatitis  [5] . Later, in the early 1990s, it was 
classified into the following 2 forms: pure, which involves 
only the groove area (space between the duodenal wall 
and pancreatic head), and segmental, with inflammation 
extending to the adjacent pancreatic head. In practice, 
this differentiation is not always possible to be clearly de-
fined  [6] . 
 Its prevalence varies largely from 2.7 to 24.5% in surgi-
cal specimens of patients with chronic pancreatitis  [5] 
and is most frequently found in men during the fifth de-
cade  [7] . Risk factors include severe alcohol consumption 
and heavy smoking  [8] and in two-thirds, it is associated 
with chronic pancreatitis  [9] .
 Various factors are implicated in PP’s etiology: pan-
creatic ectopic tissue in the duodenal wall with localized 
inflammation and scarring; absence or functional ob-
struction of the minor papilla; increased fluid viscosity, 
Brunner gland hyperplasia and intraductal pressure 
caused by chronic consumption of alcohol, as well as 
modifications of local anatomy secondary to gastroduo-
denal ulcers, gastrectomy, or biliary diseases  [8] .
 Usually patients present with upper abdominal pain 
associated with nausea and recurrent postprandial vomit-
ing  [10] . With chronicity, significant weight loss appears 
and eventually jaundice, diarrhea, and diabetes mellitus 
 [4, 11] . 
 In laboratory evaluation, a slight elevation of pancre-
atic and hepatic enzymes is frequently found  [5] . The tu-
mor markers CEA and CA 19.9 are normal, with few cas-
es describing a small raise. 
cba
 Fig. 5. D2 thickening with heterogeneous areas of hyperintense signal on magnetic resonance cholangiopancre-
atography. 
 Fig. 6. Histology showing Brunner’s gland hyperplasia ( a ), cysts in the muscular layer, ectopic pancreatic tissue 
( b ), proliferation of smooth muscle cells, and fibrosis ( c ). 
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 Diverse pathologies are included in the differential di-
agnosis: pancreatic adenocarcinoma, cystic tumors, auto-
immune pancreatitis  [8] , duodenal carcinoma, cholan-
giocarcinoma, and acute relapsing pancreatitis. The first 
one is particularly challenging even with resource to ima-
giology and endoscopic modalities  [1] .
 Imaging exams, especially MRI, are very important to 
confirm the diagnosis of PP. The spectrum of findings is 
large but the typical presentation involves focal thickening 
of the D2, cystic degeneration, and a “sheet-like” mass of 
fibrotic tissue within the groove  [3] . Other changes that 
can be found include duct abnormalities (dilation, atro-
phy, and irregularity) and signs of chronic pancreatitis  [3] . 
 Nowadays, besides MRI, EUS is also considered a gold 
standard for PP diagnosis  [2] . It reveals a hypoechoic area 
between the duodenal wall and the head of the pancreas, 
thickening and stenosis of the duodenal wall, intramural 
cysts and a slightly narrowing of the main biliary duct. 
Eventually, in cases of segmental PP, it is possible to see 
infiltration and calcification of pancreatic parenchyma, 
pseudocysts, and dilation of pancreatic duct  [1, 4] . EUS-
FNA has limited value in this setting and depends on the 
biopsy site and its interpretation, being difficult to ex-
clude a subjacent tumor  [6] . Upper gastrointestinal en-
doscopy usually shows a swollen and polypoid duodenal 
mucosa and stenosis; however, biopsies are frequently in-
conclusive  [8] . Endoscopic retrograde cholangiopancrea-
tography can be difficult or even impossible due to duo-
denal stenosis. When successful, it may reveal distal ste-
nosis of the main biliary duct or irregularities of Wirsung 
and Santorini ducts  [4] .
 Histologically, the most characteristic findings consist 
of myofibroblastic and neural expansion into the groove 
area, thickening of the duodenal wall with fibrosis and 
Brunner’s gland and smooth muscle hyperplasia, occur-
rence of dilated ducts as well as pseudocysts within the 
duodenal wall, and the presence of hypercellullar granu-
lation tissue and foreign body type giant cells  [1, 12] . Cy-
tology from fragments obtained by EUS can show a wide 
range of results, frequently with observation of spindled 
stromal cells. Although the majority is interpreted as neg-
ative for malignancy, the results can be misinterpreted as 
a tumor, especially if there is an abundance of Brunner 
gland hyperplasia and spindle cells  [6, 12] .
 Currently, its treatment is based on a stepwise ap-
proach, which can be effective with an acceptable compli-
cation rate  [9] . Conservative measures involve the absti-
nence of alcohol and tobacco, pancreatic rest, and anal-
gesics, the first one being crucial for long-term results  [8] . 
Recently, somatostatin analogs were considered an alter-
native medical option. However, few reports are de-
scribed in literature and symptomatology recurrence 
seems to be frequent after treatment cessation  [4] . 
 Endoscopic treatment, such as stricture dilation and 
cysts or pancreatic ductal drainage, is an important non-
surgical approach with good results. In a study conducted 
by Arvanitakis et al.  [9]  involving 51 patients, this ap-
proach, together with medical treatment, had a high rate 
of clinical success (nearly 80%) and showed low adverse 
effects.
 If symptoms do not improve with the previous strate-
gies, complications appear, or when a suspicion of a neo-
plasm is present, surgery must be the treatment of choice. 
The technique usually performed is the Whipple proce-
dure  [4] , but some authors sustain that more conservative 
interventions, such as suprapapillary segmental duodenal 
resection, should be considered in cases of isolated duo-
denal dystrophy  [13] . Apart of the procedure used, it is 
proved that surgery highly improves quality of life and 
contributes to pain cessation  [2] .
 In conclusion, PP should be considered in the differ-
ential diagnosis of pancreatic head masses with duodenal 
infiltration. Its treatment should be individualized to 
each case, choosing a conservative management when-
ever possible. 
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Erratum
In the article by Carvalho et al. entitled “Paraduodenal Pancreatitis: Three Cases with Dif-
ferent Therapeutic Approaches” [GE Port J Gastroenterol 2017;24:89–94, DOI: 10.1159/
000450872], figures 1 and 2 have erroneously been exchanged. Figure legend 1 refers to 
figure 2 (MRI), and figure legend 2 refers to figure 1 (EUS).
